Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
K(+) channel alterations in the progression of experimental autoimmune encephalomyelitis.
The elusive biomarker for personalized medicine in multiple sclerosis: The search continues.
Association of Neuromyelitis Optica With Severe and Intractable Pain.
Two-year serial whole-brain N-acetyl-L-aspartate in patients with relapsing-remitting multiple sclerosis.
Shared HLA Class II in Six Autoimmune Diseases in Latin America: A Meta-Analysis.
Dementia in multiple sclerosis: Report of a case with cortical gray matter involvement and frontotemporal-like clinical features.
Visual evoked potentials in early diagnosis of demyelinating diseases - a case report of Devic's disease.
Teva and Active Biotech Announce Expansion of Laquinimod Clinical Development Program with New Trial in Primary Progressive Multiple Sclerosis and First Patient Screened in Huntington's Disease Trial
Pilates exercise training vs. physical therapy for improving walking and balance in people with multiple sclerosis: A randomized controlled trial.
Cerebrospinal fluid analysis.
Exacerbation of experimental autoimmune encephalomyelitis after withdrawal of phenytoin and carbamazepine.
Vitamin D status and the risk of multiple sclerosis: A systematic review and meta-analysis.
Symptoms, Prevalence and Impact of Multiple Sclerosis in Younger Patients: A Multinational Survey.
B-89Comparison of Driving Performance, Cognition, and Physical Symptoms in Individuals with Multiple Sclerosis and Healthy Controls.
Physical fitness assessment in multiple sclerosis patients: A controlled study.
The Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ): development of a shortened scale.
Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis.
Deimination restores inner retinal visual function in murine demyelinating disease.
Cortical pathology in multiple sclerosis: experimental approaches to studies on the mechanisms of demyelination and remyelination.
The thalamus and multiple sclerosis: Modern views on pathologic, imaging, and clinical aspects.
The pathogenic role of the inflammasome in neurodegenerative diseases.
Interplaying factors that effect multiple sclerosis causation and sustenance.
Efficacy of vision restoration therapy after optic neuritis (VISION study): study protocol for a randomized controlled trial.
Altered natural killer cells' response to herpes virus infection in multiple sclerosis involves KIR2DL2 expression.
Galanin Transgenic Mice with Elevated Circulating Galanin Levels Alleviate Demyelination in a Cuprizone-Induced MS Mouse Model.
Pages
« first
‹ previous
…
246
247
248
249
250
251
252
253
254
…
next ›
last »